Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Anika Therapeutics Inc ANIK

Healthcare Biotechnology
Anika Therapeutics, Inc. is a joint preservation company focused on developing, manufacturing, and commercializing products based on hyaluronic acid (HA) technology platform. The OA Pain Management product family consists of Monovisc and Orthovisc that provides pain relief from osteoarthritis conditions and Cingal consisting of its cross-linked HA material combined with a fast-acting steroid... see more

Recent & Breaking News (NDAQ:ANIK)

Anika Reports Second Quarter 2023 Financial Results

GlobeNewswire August 8, 2023

Anika to Issue Second Quarter 2023 Financial Results on Tuesday, August 8, 2023

GlobeNewswire July 20, 2023

Anika Showcases Highly Differentiated Joint Preservation and Restoration Portfolio at the 2023 AOSSM Annual Meeting

GlobeNewswire July 12, 2023

Anika Completes Enrollment in Hyalofast® U.S. Pivotal Phase III Study Achieving Key Milestone

GlobeNewswire May 30, 2023

Anika Reports First Quarter 2023 Financial Results

GlobeNewswire May 9, 2023

Anika to Issue First Quarter 2023 Financial Results on Tuesday, May 9, 2023

GlobeNewswire April 19, 2023

Anika Enters Into Cooperation Agreement with Caligan Partners

GlobeNewswire April 13, 2023

Anika to Participate in the 22nd Annual Needham Virtual Healthcare Conference

GlobeNewswire April 12, 2023

Anika Continues to Expand Addressable Market for Tactoset® Injectable Bone Substitute with Additional 510(k) Clearance from FDA

GlobeNewswire April 3, 2023

Anika Files Preliminary Proxy Statement

GlobeNewswire March 27, 2023

Anika to Participate in the Sidoti Small Cap Virtual Investor Conference

GlobeNewswire March 15, 2023

Anika Highlights Products in High Growth Segments of Joint Preservation during the 2023 AAOS Annual Meeting

GlobeNewswire March 8, 2023

Anika Reports Fourth Quarter and Year-End Fiscal 2022 Financial Results

GlobeNewswire March 6, 2023

Anika to Participate in the Canaccord Genuity Musculoskeletal Conference

GlobeNewswire February 28, 2023

Anika to Issue Fourth Quarter and Year-End 2022 Financial Results on Monday, March 6, 2023

GlobeNewswire February 21, 2023

Anika Issues Statement

GlobeNewswire February 21, 2023

Caligan Partners Issues Open Letter to Anika Board

PR Newswire February 21, 2023

Anika Announces First Surgeries Performed Using the New RevoMotion(TM) Reverse Shoulder Arthroplasty System and Commences Limited Market Release in the United States

GlobeNewswire February 13, 2023

Anika Reports Third Quarter Fiscal 2022 Financial Results

GlobeNewswire November 8, 2022

Anika's Cingal® Successfully Achieves Primary Endpoint in Third Phase III Study

GlobeNewswire November 1, 2022